Systemic Gene Transfer to Skeletal Muscle Using Reengineered AAV Vectors

6Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Gene therapy of musculoskeletal disorders warrants efficient gene transfer to a wide range of muscle groups. Reengineered adeno-associated viral (AAV) vectors that selectively transduce muscle tissue following systemic administration are attractive candidates for such applications. Here we provide examples of several lab-derived AAV vectors that display systemic tissue tropism in mice. Methods to evaluate the efficiency of gene transfer to skeletal muscle following intravenous or isolated limb infusion of AAV ­vectors in mice are discussed in detail.

Cite

CITATION STYLE

APA

Phillips, J. L., Hegge, J., Wolff, J. A., Samulski, R. J., & Asokan, A. (2011). Systemic Gene Transfer to Skeletal Muscle Using Reengineered AAV Vectors. In Methods in Molecular Biology (Vol. 709, pp. 141–151). Humana Press Inc. https://doi.org/10.1007/978-1-61737-982-6_9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free